Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth
Launched by CAIRO UNIVERSITY · Nov 9, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to compare three different materials used in dental treatment for patients with deep cavities in their permanent teeth. The materials being tested are Egyptian MTA, Biodentine, and Calcium Hydroxide. The goal is to see which of these materials works best in terms of healing and patient satisfaction after indirect pulp capping, a procedure that helps protect the tooth’s nerve.
To participate in this study, you need to be an adult between 22 and 45 years old, have a tooth with a deep cavity, and be in good health with good oral hygiene. If you decide to join, you’ll receive one of the three materials during your dental treatment and will help researchers understand how effective it is. It's important to note that people with certain health issues or allergies, as well as those who struggle with oral hygiene, won't be eligible to join. This study is not yet recruiting participants but aims to provide valuable information on dental treatments that can improve patient care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients aged 22: 45 years old.
- • Males or females.
- • Patients with vital teeth with deep carious lesions.
- • Patients in good general health.
- • Good oral hygiene.
- • Co-operative patients who show interest to participate in the study.
- Exclusion Criteria:
- • Patients with systemic diseases.
- • Patients with known allergic or adverse reaction to the tested materials.
- • Patients with bad oral hygiene.
- • Patient who frequently use analgesic or any drugs that could mask the pain.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported